| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
39,897,000 |
| Market
Cap: |
421.31(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$10.16 - $28.33 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Nevro is a medical device company that has developed and commercialized the Senza® spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain, with the Senza® Omnia™ platform as an addition to the Senza family of products. Co.'s HF10 therapy, delivered by its Senza system is designed to treat back pain and leg pain. The Senza system is approved to create electrical impulses and its HF10 therapy for pain relief without paresthesia. HF10 therapy delivers waveforms with a programming algorithm. Senza is consisted of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician programmer, a patient remote control and a mobile charger.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
7,500 |
7,500 |
| Total Buy Value |
$0 |
$0 |
$171,633 |
$171,633 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Elghandour Rami |
President & CEO |
• • – |
2019-01-03 |
4 |
D |
$35.52 |
$102,937 |
D/D |
(2,898) |
122,387 |
|
- |
|
| Rashid Kashif |
General Counsel |
• – – |
2019-01-02 |
4 |
D |
$36.55 |
$37,354 |
D/D |
(1,022) |
25,561 |
|
- |
|
| Schmitz Patrick |
Vice President, Operations |
• – – |
2018-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
8,250 |
20,609 |
|
- |
|
| Rashid Kashif |
General Counsel |
• – – |
2018-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
16,250 |
26,250 |
|
- |
|
| Alleavitch Doug |
VP, Quality |
• – – |
2018-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
8,250 |
25,985 |
|
- |
|
| Christoforou Christofer |
VP, Research & Development |
• – – |
2018-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
5,500 |
21,686 |
|
- |
|
| Alleavitch Doug |
VP, Quality |
• – – |
2018-11-01 |
4 |
D |
$49.40 |
$41,941 |
D/D |
(849) |
17,735 |
|
- |
|
| Galligan Andrew H |
Chief Financial Officer |
• – – |
2018-11-01 |
4 |
D |
$49.40 |
$121,376 |
D/D |
(2,457) |
33,135 |
|
- |
|
| Schmitz Patrick |
Vice President, Operations |
• – – |
2018-11-01 |
4 |
D |
$49.40 |
$41,941 |
D/D |
(849) |
12,359 |
|
- |
|
| Christoforou Christofer |
VP, Research & Development |
• – – |
2018-11-01 |
4 |
D |
$49.40 |
$38,384 |
D/D |
(777) |
16,186 |
|
- |
|
| Elghandour Rami |
President & CEO |
• • – |
2018-11-01 |
4 |
D |
$49.40 |
$215,779 |
D/D |
(4,368) |
125,285 |
|
- |
|
| Elghandour Rami |
President & CEO |
• • – |
2018-09-17 |
4 |
OE |
$3.60 |
$66,240 |
D/D |
18,400 |
129,653 |
|
- |
|
| Christoforou Christofer |
VP, Research & Development |
• – – |
2018-08-02 |
4 |
D |
$59.55 |
$51,451 |
D/D |
(864) |
16,963 |
|
- |
|
| Alleavitch Doug |
VP, Quality |
• – – |
2018-08-01 |
4 |
OE |
$53.70 |
$53,700 |
D/D |
1,000 |
18,584 |
|
- |
|
| Alleavitch Doug |
VP, Quality |
• – – |
2018-07-25 |
4 |
OE |
$53.70 |
$80,550 |
D/D |
1,500 |
17,584 |
|
- |
|
| Galligan Andrew H |
Chief Financial Officer |
• – – |
2018-07-18 |
4 |
OE |
$1.44 |
$10,656 |
D/D |
7,400 |
35,592 |
|
- |
|
| Elghandour Rami |
President & CEO |
• • – |
2018-06-01 |
4 |
D |
$77.44 |
$611,311 |
D/D |
(7,894) |
111,253 |
|
- |
|
| Mccormick Shawn |
Director |
– • – |
2018-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,785 |
5,303 |
|
- |
|
| Demane Michael F |
Director |
– • – |
2018-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,785 |
476,301 |
|
- |
|
| Fischer Frank M |
Director |
– • – |
2018-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,785 |
34,453 |
|
- |
|
| Vale Brad |
Director |
– • – |
2018-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,785 |
7,303 |
|
- |
|
| Earnhardt Lisa |
Director |
– • – |
2018-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,785 |
5,303 |
|
- |
|
| Jaeger Wilfred E |
Director |
– • – |
2018-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,785 |
5,303 |
|
- |
|
| Behbahani Ali |
Director |
– • – |
2018-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,785 |
5,390 |
|
- |
|
| Galligan Andrew H |
Chief Financial Officer |
• – – |
2018-05-14 |
4 |
AS |
$76.14 |
$532,959 |
D/D |
(7,000) |
28,192 |
|
- |
|
555 Records found
|
|
Page 13 of 23 |
|
|
0.68 (6.88%) 
